On November 10, 2026, the Federal Trade Commission announced that Arizona, Florida, Nebraska, Ohio, and Wisconsin have joined its lawsuit against Hims & Hers Health, Inc. The states came in through a first amended complaint in the U.S. District Court for the Northern District of California, joining Utah and California (acting through Los Angeles County Counsel), which were part of the original case filed in July. That puts the FTC and seven states on the same side of one case against one of the largest direct-to-consumer telehealth brands in the country.
Hims & Hers disputes the claims, and a company spokesperson told Reuters it will vigorously defend itself, calling the new claims follow-ons that rely on the same flawed allegations as the government's original suit.
What the case is about
The core story has not changed since July. In plain terms, the government is saying three things:
- Health information went to advertisers. Hims told consumers their information was private while sharing health information with advertising platforms including Meta and Snap. The amended complaint says roughly 14 million customer email addresses were uploaded to Meta between September 2020 and June 2023, and that sharing with advertising platforms continued through at least May 2024.
- "$0 due now" was not really $0. The final intake screen showed "Due Now $0," a "Pay $0 today" button, and the line "You will only be charged if prescribed," but the complaint says most people were charged and enrolled in a subscription almost immediately after submitting the intake form, without a consultation with a provider. The complaint also says Hims changed one of those screens in late 2025, after learning about the FTC investigation.
- Billing and cancellation did not follow subscription rules. These claims run under the Restore Online Shoppers' Confidence Act (ROSCA), the federal law that requires clear terms before billing, express consent before charging, and a simple way to cancel.
What changed with the amendment
The amended complaint now has 16 counts. The FTC brings the privacy and intake claims on its own under Section 5 of the FTC Act. The ROSCA billing and cancellation claims are now brought by the FTC together with California and the five new states, because ROSCA allows state officials to sue to enforce it. On top of that, each state adds claims under its own consumer protection law:
- Arizona: Consumer Fraud Act
- Florida: Deceptive and Unfair Trade Practices Act, under both the deceptive and the unfair prongs
- Nebraska: Uniform Deceptive Trade Practices Act
- Ohio: Consumer Sales Practices Act, including Ohio's administrative rule on when a business can call something "free"
- Wisconsin: Deceptive Trade Practices Act
- Utah and California keep the state claims they brought in July
The relief sought now includes civil penalties under each state's own schedule, in addition to the injunction and monetary relief the FTC was already seeking.
Why "per violation" is the number that matters in healthcare
Most of these laws set penalties per violation, not per case. Arizona allows up to $10,000 for each willful violation, and in Arizona "willful" only means the company knew or should have known the conduct was prohibited. California allows up to $2,500 for each violation under its Unfair Competition Law and another $2,500 for each violation under its False Advertising Law. On the federal side, violations of ROSCA are treated like violations of an FTC rule, and the FTC's maximum civil penalty for rule violations is currently $53,088 per violation.
The question that decides how big a case gets is what counts as one violation, and regulators get to argue that. It can be each consumer, each charge, each ad someone saw, or each day the practice continued. California's case against Johnson & Johnson over pelvic mesh marketing is the example people point to. The court counted individual marketing communications as separate violations, found more than 150,000 violations of the Unfair Competition Law and more than 120,000 of the False Advertising Law, and imposed $1,250 per violation, which is half the maximum. That came to $344 million, later reduced on appeal to $302 million, and the U.S. Supreme Court declined to hear J&J's challenge.
Now apply that to a subscription telehealth company. Say you have 200,000 members on a monthly plan, and a regulator decides your checkout did not get proper consent or your cancellation flow did not meet the rules. Every monthly charge to every member can be argued as its own violation, so one year of billing is 2.4 million charges. At the $1,250 rate California used against J&J, that is $3 billion on paper in a single state, before you add other states or the privacy side of the case, where the Hims complaint points to millions of tracking events tied to specific medical treatments.
No one actually expects a court to land on a number like that. California's law tells courts to weigh how serious the conduct was, how many violations there were, how long it went on, how willful it was, and what the company can afford. But that theoretical number is where negotiations start, and it is why companies settle. When a regulator opens an investigation, one of the first things they ask for is your volume, meaning how many members, how many renewals, how many cancellation requests, and how long the practice ran. In healthcare, where the business model is recurring care, recurring refills, and recurring charges, the same mistake repeats every billing cycle for every patient, and each repetition is another violation on the count.
It is also why each new state matters. Every state that joins brings its own penalty schedule and its own count of residents who were affected.
Reading between the lines
When the original complaint was filed, my read was that regulators are reaching direct-to-consumer telehealth through borrowed statutes, because there is very little telemedicine-specific law for them to enforce. This amendment is the same playbook, just multiplied across more states.
None of the new state claims come from telehealth laws. They are general consumer protection statutes that every state already has on the books, the same ones used against gyms, car dealers, and subscription boxes. As Venable pointed out after the July filing, the FTC did not rely on the Health Breach Notification Rule, and the states did not bring their privacy claims under newer health data privacy laws, choosing instead to stick with their deceptive and unfair practices statutes. That matters, because those statutes are broad and well tested, and the government only has to show that a representation was misleading and mattered to consumers, not that a company broke a rule written specifically for telehealth.
It also tells you something about how the clinical and commercial sides of a telehealth company are treated. Every claim in this case is about the commercial layer, meaning the marketing, the intake funnel, the checkout, the subscription, and the tracking on the website. That is the part of the business that usually sits outside HIPAA and inside the consumer-facing company or MSO, and it is exactly where consumer protection law lives. A clean PC/MSO structure protects the clinical side, but it does not protect a misleading checkout page.
The other thing worth noticing is how cheap it is for a state to join. A national telehealth brand sells into every state, so every state attorney general has a stake and a penalty schedule of its own. Once the FTC has done the investigative work (Hims has described it as a nearly three-year investigation), a state can attach its own claims to a case that is already built. I would not be surprised to see this pattern repeat in future telehealth enforcement, where the FTC develops the case and states sign on to it.
Ohio's "free" rule is a good example of how specific the state layer can get. A "free consultation" or "$0 today" banner is a marketing choice a lot of telehealth companies make without a second thought, and some states have rules written specifically about when and how you can use that word.
What telehealth companies should take from this
- Make your privacy claims match your tracking. Audit the pixels and audience uploads on your intake, checkout, and confirmation pages and compare them to what your website, ads, and influencers promise patients.
- Walk through your intake flow as a patient. If a button says $0 and a card gets charged the moment a prescription is written, fix the wording, the charge timing, or both.
- Make cancellation simple. Under ROSCA, cancelling should be about as easy as signing up, without a phone call requirement or a long survey before it goes through.
- Review marketing against the strictest state you sell into. Federal rules are the floor. "Free" claims, auto-renewal disclosures, and subscription terms all have state-specific rules, and California's Automatic Renewal Law is a common one.
- Treat this as an operations problem, not a policy document. This case is about what actually happened in the flows, not what the privacy policy said, so the fix is testing and monitoring the live experience on a regular schedule.
How I help
I help telehealth companies and practices review their patient-facing experience, including intake, checkout, subscriptions, cancellation, tracking, and marketing claims, against federal and state rules, and then build the compliance processes that keep it that way as the business grows. If you want a second set of eyes on your funnel before a regulator takes a look, reach out at caminostrategygroup.com.
Related reading
- What the FTC Lawsuit Against Hims & Hers Means for Telehealth Companies
- Why LegitScript Is in the News for Not Overseeing Vendors Correctly
This post is general information and is not legal advice. The allegations in this case have not been proven, and Hims & Hers disputes them.
Sources
- FTC: Five states join FTC lawsuit alleging Hims & Hers engaged in deceptive and unlawful privacy practices
- FTC: FTC and states act against Hims & Hers for deceptive and unlawful privacy practices (July 2026)
- Reuters via WSAU: Five US states join FTC lawsuit against Hims & Hers
- Recording Law: Five more states join FTC suit over Hims and Hers privacy claims
- Venable: FTC and states take action against Hims & Hers, key privacy takeaways
- PYMNTS: Hims & Hers faces widening FTC lawsuit as five states join privacy case
- ConsumerAffairs: FTC sues Hims & Hers over alleged privacy violations and deceptive billing
- Shumaker: FTC and states sue Hims & Hers over deceptive health data sharing and subscription billing practices
- FTC: First amended complaint, FTC v. Hims & Hers Health, Inc.
- PPC Land: Hims & Hers faces seven states as five join FTC privacy and billing suit
- McDermott: FTC takes aim at Hims & Hers' subscription and health-data practices
- Arizona Revised Statutes 44-1531: Violations; civil penalties
- California Business and Professions Code 17206
- California Business and Professions Code 17536
- FTC: Adjustments to civil penalty amounts (Federal Register, January 2025)
- FTC: No civil penalty inflation adjustment for 2026 (Federal Register, September 2026)
- NAAG: Supreme Court denies J&J petition in pelvic mesh civil penalty case
- MedTech Dive: Appeals court rules J&J must pay $302 million over pelvic mesh marketing




